Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226577
Status:
COMPLETED
Last Update Posted:
2017-03-23
First Post:
2005-09-23
Brief Title:
Pharmacogenomic Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Organization Data
Organization:
H Lee Moffitt Cancer Center and Research Institute
Class:
OTHER
Study ID:
MCC-13726
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| National Cancer Institute NCI | NIH |